| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Core Laboratories (NYSE:CLB) just disclosed its Q4 earnings on Wednesday, January 29, 2025 at 04:46 PM.
Here's a brief overview of the earnings report.
Core Laboratories missed estimated earnings by 0.0%, reporting an EPS of $0.22 versus an estimate of $0.22.
Revenue was up $1.03 million from the same period last year.
The company beat on EPS by $0.02 in the last quarter, resulting in a 11.0% increase share price change the following day.
Here's a look at Core Laboratories's past performance:
| Quarter | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| EPS Estimate | 0.23 | 0.21 | 0.16 | 0.19 |
| EPS Actual | 0.25 | 0.22 | 0.19 | 0.19 |
| Revenue Estimate | 134.45M | 131.84M | 124.44M | 127.77M |
| Revenue Actual | 134.40M | 130.58M | 129.64M | 128.21M |
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Core Laboratories management provided guidance for Q1 2025, expecting earnings between $0.12 and $0.16 per share.
To track all earnings releases for Core Laboratories visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CLB
